![(3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide structure](/static/products/392/392316-95-9.png)
(3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide
TL;DR: (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide (CAS 392316-95-9) is a chemical compound with molecular formula C18H15ClN4O3 and molecular weight 370.08 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
5-chloro-N-[(E)-[4-(2-cyanoanilino)-4-oxobutan-2-ylidene]amino]-2-hydroxybenzamide
Also Known As: (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide, (E)-3-(2-(5-chloro-2-hydroxybenzoyl)hydrazono)-N-(2-cyanophenyl)butanamide, (3E)-4-[(5-chloro-2-hydroxyphenyl)carbonylamino]-N-(2-cyanophenyl)-3-methyl-4- azabut-3-enamide
| Molecular Formula | C18H15ClN4O3 |
|---|---|
| Molecular Weight | 370.08 g/mol |
| LogP | 3.05178 |
| Topological Polar Surface Area | 114.58 Ų |
| Hydrogen Bond Donors | 3 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Exact Mass | 370.08328 |
| Heavy Atoms | 26 |
| Complexity | 918.8925 |
Chemical Identifiers
| CAS Number | 392316-95-9 |
|---|---|
| SMILES | C/C(=N\NC(=O)C1=C(C=CC(=C1)Cl)O)/CC(=O)NC2=CC=CC=C2C#N |
Product Overview
(3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide (CAS 392316-95-9), with molecular formula C18H15ClN4O3 and molecular weight 370.08 g/mol. IUPAC: 5-chloro-N-[(E)-[4-(2-cyanoanilino)-4-oxobutan-2-ylidene]amino]-2-hydroxybenzamide.
Chemical Property Profile of (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide
Property Insights of (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide
The XLogP value of 3.05178 indicates that (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 114.58 Ų falls within the moderate polarity range, balancing permeability and solubility for (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide. Following Lipinski's Rule of Five, (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide has 3 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide?
The CAS number of (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide is 392316-95-9.
What is the molecular formula of (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide?
The molecular formula of (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide is C18H15ClN4O3.
What is the molecular weight of (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide?
The molecular weight of (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide is 370.08 g/mol.
Where can I buy (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide?
You can request a quote for (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide?
Yes, KEHONG BIO provides custom synthesis services for (3E)-3-{2-[(5-chloro-2-hydroxyphenyl)carbonyl]hydrazinylidene}-N-(2-cyanophenyl)butanamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.